{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:58:11Z","timestamp":1784339891069,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06354-z","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:44:16Z","timestamp":1762865056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A clinical report and analysis of metachronous multiple primary cancers occurred in four sites"],"prefix":"10.1007","volume":"151","author":[{"given":"Rongze","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"10","key":"6354_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103714","volume":"9","author":"E Agostinetto","year":"2024","unstructured":"Agostinetto E et al (2024) Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology. ESMO Open 9(10):103714","journal-title":"ESMO Open"},{"issue":"23","key":"6354_CR2","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1002\/cam4.4351","volume":"10","author":"S Bao","year":"2021","unstructured":"Bao S et al (2021) Nonmetastatic breast cancer patients subsequently developing second primary malignancy: a population-based study. Cancer Med 10(23):8662\u20138672","journal-title":"Cancer Med"},{"key":"6354_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/genes15020219","author":"V Barili","year":"2024","unstructured":"Barili V et al (2024) Genetic basis of breast and ovarian cancer: approaches and lessons learnt from three decades of inherited predisposition testing. Genes. https:\/\/doi.org\/10.3390\/genes15020219","journal-title":"Genes"},{"key":"6354_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114307","volume":"211","author":"M Bottosso","year":"2024","unstructured":"Bottosso M et al (2024) HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome. Eur J Cancer 211:114307","journal-title":"Eur J Cancer"},{"issue":"1","key":"6354_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2214\/AJR.20.23008","volume":"216","author":"N Consul","year":"2021","unstructured":"Consul N et al (2021) Li-fraumeni syndrome and whole-body MRI screening: screening guidelines, imaging features, and impact on patient management. AJR Am J Roentgenol 216(1):252\u2013263","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"6354_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","volume":"22","author":"KC de Andrade","year":"2021","unstructured":"de Andrade KC et al (2021) Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. Lancet Oncol 22(12):1787\u20131798","journal-title":"Lancet Oncol"},{"key":"6354_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116274","author":"V Ea","year":"2024","unstructured":"Ea V et al (2024) BRCA1 intragenic duplication combined with a likely pathogenic TP53 variant in a patient with triple-negative breast cancer: clinical risk and management. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25116274","journal-title":"Int J Mol Sci"},{"key":"6354_CR8","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00453","volume":"8","author":"C Fortuno","year":"2024","unstructured":"Fortuno C et al (2024) Cancer risks associated with TP53 pathogenic variants: maximum likelihood analysis of extended pedigrees for diagnosis of first cancers beyond the Li-Fraumeni syndrome spectrum. JCO Precis Oncol 8:e2300453","journal-title":"JCO Precis Oncol"},{"issue":"10","key":"6354_CR9","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","volume":"28","author":"T Frebourg","year":"2020","unstructured":"Frebourg T et al (2020) Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum Genet 28(10):1379\u20131386","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"6354_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/147323001103900237","volume":"39","author":"B Gursel","year":"2011","unstructured":"Gursel B et al (2011) Multiple primary malignant neoplasms from the Black Sea region of Turkey. J Int Med Res 39(2):667\u2013674","journal-title":"J Int Med Res"},{"issue":"5","key":"6354_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"1","key":"6354_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12672-024-01435-w","volume":"15","author":"MS Hosseini","year":"2024","unstructured":"Hosseini MS (2024) Current insights and future directions of Li-Fraumeni syndrome. Discov Oncol 15(1):561","journal-title":"Discov Oncol"},{"key":"6354_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103824","volume":"78","author":"N Hou","year":"2024","unstructured":"Hou N et al (2024) Radiotherapy and increased risk of second primary cancers in breast cancer survivors: an epidemiological and large cohort study. Breast 78:103824","journal-title":"Breast"},{"issue":"12","key":"6354_CR14","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/cncr.29841","volume":"122","author":"SC Kamran","year":"2016","unstructured":"Kamran SC et al (2016) Therapeutic radiation and the potential risk of second malignancies. Cancer 122(12):1809\u20131821","journal-title":"Cancer"},{"issue":"5","key":"6354_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ijc.35475","volume":"157","author":"E Kasper","year":"2025","unstructured":"Kasper E et al (2025) Deciphering dual clinical entities associated with TP53 pathogenic variants: insights from 53,085 HBOC panel analyses in French laboratories. Int J Cancer 157(5):897\u2013907","journal-title":"Int J Cancer"},{"key":"6354_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132346","author":"JH Kwon","year":"2024","unstructured":"Kwon JH et al (2024) Incidence and characteristics of multiple primary cancers: a 20-year retrospective study of a single cancer center in Korea. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16132346","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6354_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12885-023-11229-y","volume":"23","author":"A \u00d6fverholm","year":"2023","unstructured":"\u00d6fverholm A et al (2023) Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer 23(1):738","journal-title":"BMC Cancer"},{"issue":"1","key":"6354_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12957-021-02370-8","volume":"19","author":"J Prejac","year":"2021","unstructured":"Prejac J et al (2021) A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor. World J Surg Oncol 19(1):254","journal-title":"World J Surg Oncol"},{"issue":"1","key":"6354_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10549-011-1403-8","volume":"131","author":"M Ratajska","year":"2012","unstructured":"Ratajska M et al (2012) Cancer predisposing BARD1 mutations in breast-ovarian cancer families. Breast Cancer Res Treat 131(1):89\u201397","journal-title":"Breast Cancer Res Treat"},{"key":"6354_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836937","volume":"12","author":"RL Sandoval","year":"2022","unstructured":"Sandoval RL et al (2022) Breast cancer phenotype associated with Li-Fraumeni syndrome: a Brazilian cohort enriched by TP53 p. R337H carriers. Front Oncol 12:836937","journal-title":"Front Oncol"},{"issue":"2","key":"6354_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/IGC.0000000000000045","volume":"24","author":"T Shimada","year":"2014","unstructured":"Shimada T et al (2014) Secondary leukemia after chemotherapy and\/or radiotherapy for gynecologic neoplasia. Int J Gynecol Cancer 24(2):178\u2013183","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"6354_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1159\/000533391","volume":"18","author":"D Speiser","year":"2023","unstructured":"Speiser D, Bick U (2023) Primary prevention and early detection of hereditary breast cancer. Breast Care (Basel) 18(6):448\u2013454","journal-title":"Breast Care (Basel)"},{"key":"6354_CR23","unstructured":"The Surveillance E, End Results (SEER) 2025\/8\/2; Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"issue":"7","key":"6354_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jgg.2021.12.012","volume":"49","author":"P Tian","year":"2022","unstructured":"Tian P et al (2022) Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients. J Genet Genomics 49(7):645\u2013653","journal-title":"J Genet Genomics"},{"issue":"7","key":"6354_CR25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/cas.12433","volume":"105","author":"M Utada","year":"2014","unstructured":"Utada M et al (2014) Incidence of multiple primary cancers and interval between first and second primary cancers. Cancer Sci 105(7):890\u2013896","journal-title":"Cancer Sci"},{"issue":"3","key":"6354_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood-2013-10-532184","volume":"124","author":"AM van Eggermond","year":"2014","unstructured":"van Eggermond AM et al (2014) Risk of multiple primary malignancies following treatment of Hodgkin lymphoma. Blood 124(3):319\u2013327","journal-title":"Blood"},{"key":"6354_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znad377","author":"X Wang","year":"2024","unstructured":"Wang X et al (2024) Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients. Br J Surg. https:\/\/doi.org\/10.1093\/bjs\/znad377","journal-title":"Br J Surg"},{"issue":"4","key":"6354_CR28","first-page":"779","volume":"93","author":"S Warren","year":"1932","unstructured":"Warren S (1932) Multiple primary malignant tumors: a survey of the literature and a statistical study. Gastroenterology 93(4):779","journal-title":"Gastroenterology"},{"key":"6354_CR29","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13528","volume":"10","author":"L Xiao","year":"2022","unstructured":"Xiao L et al (2022) Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in female patients with breast cancer or genitalia malignancies. PeerJ 10:e13528","journal-title":"PeerJ"},{"issue":"10 Suppl","key":"6354_CR30","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1007\/s10350-006-0600-8","volume":"49","author":"S Yamamoto","year":"2006","unstructured":"Yamamoto S et al (2006) The risk of multiple primary malignancies with colorectal carcinoma. Dis Colon Rectum 49(10 Suppl):S30\u2013S36","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"6354_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","volume":"28","author":"R Yoshida","year":"2021","unstructured":"Yoshida R (2021) Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer 28(6):1167\u20131180","journal-title":"Breast Cancer"},{"key":"6354_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137481","author":"A Yoshimura","year":"2022","unstructured":"Yoshimura A, Imoto I, Iwata H (2022) Functions of breast cancer predisposition genes: implications for clinical management. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23137481","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06354-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06354-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06354-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T19:39:00Z","timestamp":1765654740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06354-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6354"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06354-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7544436\/v1","asserted-by":"object"}]},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient and the patient\u2019s family for publication of this case report and any accompanying data. All data have been anonymized to protect patient identity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"319"}}